Connection

Scott Eblen to Animals

Back to Details
This is a "connection" page, showing publications Scott Eblen has written about Animals.
Scott Eblen
Connection Strength
0.333
Animals
  1. Targeting Chromatin Remodeling for Cancer Therapy. Curr Mol Pharmacol. 2019; 12(3):215-229.
    View in: PubMed
    Score: 0.048
  2. Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes. Adv Cancer Res. 2018; 138:99-142.
    View in: PubMed
    Score: 0.045
  3. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
    View in: PubMed
    Score: 0.034
  4. Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion. Nucleic Acids Res. 2013 May; 41(9):4949-62.
    View in: PubMed
    Score: 0.032
  5. Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion. Mol Cell Biol. 2012 Jul; 32(14):2880-93.
    View in: PubMed
    Score: 0.030
  6. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD. J Proteomics. 2011 Dec 21; 75(2):603-9.
    View in: PubMed
    Score: 0.029
  7. Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion. Mol Cell Biol. 2004 Mar; 24(6):2308-17.
    View in: PubMed
    Score: 0.017
  8. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J Biol Chem. 2003 Apr 25; 278(17):14926-35.
    View in: PubMed
    Score: 0.016
  9. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol Cell Biol. 2002 Sep; 22(17):6023-33.
    View in: PubMed
    Score: 0.015
  10. HUNK phosphorylates EGFR to regulate breast cancer metastasis. Oncogene. 2020 01; 39(5):1112-1124.
    View in: PubMed
    Score: 0.013
  11. Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor ? Coactivator-1a by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological Conditions. J Biol Chem. 2016 Dec 23; 291(52):26850-26859.
    View in: PubMed
    Score: 0.010
  12. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity. Cancer Res. 1995 May 01; 55(9):1994-2000.
    View in: PubMed
    Score: 0.009
  13. Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor beta 1 in cycling epithelial cells. Cell Growth Differ. 1994 Feb; 5(2):109-16.
    View in: PubMed
    Score: 0.009
  14. Oncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner. J Biol Chem. 2012 Sep 14; 287(38):31794-803.
    View in: PubMed
    Score: 0.008
  15. MEK1 activation by PAK: a novel mechanism. Cell Signal. 2007 Jul; 19(7):1488-96.
    View in: PubMed
    Score: 0.005
  16. MEK partner 1 (MP1): regulation of oligomerization in MAP kinase signaling. J Cell Biochem. 2005 Mar 01; 94(4):708-19.
    View in: PubMed
    Score: 0.005
  17. Identifying specific kinase substrates through engineered kinases and ATP analogs. Methods. 2004 Apr; 32(4):389-97.
    View in: PubMed
    Score: 0.004
  18. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol. 2003 Jul 21; 162(2):281-91.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.